The AHA July 26 submitted a letter expressing concerns in response to the recently introduced 340B Affording Care for Communities and Ensuring a Strong Safety-Net (340B ACCESS) Act. The bill, which purports to 鈥渆stablish critical oversight and transparency of the 340B program,鈥 would dramatically diminish the program through an extremely narrow patient definition, severely limited eligibility and child site requirements, and the promise of harsh civil monetary penalties for violations.

AHA also released a new infographic that offers data-driven examples of how the 340B ACCESS Act would dismantle the 340B program and undermine its purpose 鈥 to allow eligible providers to expand access to care for more patients and communities across the country.

Related News Articles

Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation鈥
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from鈥
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state鈥檚 law protecting 340B pricing for contract pharmacy arrangements. The鈥
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥
Headline
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model 鈥渨as within its statutory鈥
Headline
The AHA this week filed a number of friend-of-the-court briefs in cases before the U.S. District Court for the District of Columbia, urging the court to uphold鈥